Pedometers alone do not increase mobility in inpatient rehabilitation: a randomized controlled trial.


Journal

Clinical rehabilitation
ISSN: 1477-0873
Titre abrégé: Clin Rehabil
Pays: England
ID NLM: 8802181

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 9 4 2019
medline: 14 11 2019
entrez: 9 4 2019
Statut: ppublish

Résumé

To test if pedometers, as a motivational tool, could affect mobility outcomes in inpatient rehabilitation. Randomized controlled clinical trial. Subacute hospital rehabilitation unit in Australia. A total of 78 participants with reduced mobility and clinician-determined capacity to improve. Both groups received usual care. For the intervention group, a pedometer was worn on the hip with the step count visible to participant and recorded daily on an exercise log. For the control group, a pedometer fixed shut was worn on the hip and they recorded estimated distances walked on an exercise log. Primary outcome was functional mobility - De Morton Mobility Index. Secondary outcome measures were walking velocity, functional independence measure, time spent upright and daily step count. Significant improvements over time ( Pedometers as a motivational tool without targets do not improve functional mobility in this population. Pedometers may improve daily upright time in this setting.

Identifiants

pubmed: 30955362
doi: 10.1177/0269215519838312
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1382-1390

Auteurs

Amy Atkins (A)

1 Clinical Rehabilitation, College of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia.
2 Launceston General Hospital, Tasmanian Health Service, Launceston, TAS, Australia.

John Cannell (J)

2 Launceston General Hospital, Tasmanian Health Service, Launceston, TAS, Australia.

Christopher Barr (C)

1 Clinical Rehabilitation, College of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH